Nature, November 22, 2011 by Monya Baker
http://www.nature.com/news/stem-cell-pioneer-bows-out-1.9407
Geron controls extensive intellectual property relevant to human ES-cell therapy, says Ken Taymor, a stem-cell patent expert at the University of California, Berkeley, and it may now be more willing to license this portfolio to help others pursuing such therapies.
